Catalysts with 'kid gloves' gently replace hydrogen with delicate bioactive entities
Pharmaceuticals improve life expectancy, quality of life and health outcomes for countless conditions and diseases, yet their development is struggling to realise its full potential. This is in large part due to the characteristics of the ubiquitous, essential yet hard-to-break carbon–hydrogen (C–H) bond. Pulling hydrogens off bioactive molecules and replacing them with functional entities requires harsh reaction conditions unsuitable for the "survival" of many of these functional groups. The EU-funded RuCat project has the key to unlock the door to functionalisations not previously possible thanks to its exceptional new catalysts for C–H activation.
Fields of science
Funding SchemeERC-ADG - Advanced Grant
M13 9PL Manchester
See on map